Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


9 Items
Title  Creator  Group name  Publishing year 
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies Del Rio et al. EquipePM Mar 08 2017
Antibody targeting of claudin-1 as a potential colorectal cancer therapy Cherradi et al. EquipeMY 06 28, 2017
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer Marzi et al. EquipeLL Nov 08, 2016
Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients Mbatchi et al. EquipeCG Apr 26 2016
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis Dalloneau et al. EquipeCG Jun 15 2016
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies Vera et al. EquipeCG Nov 27 2015
FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance Westover et al. EquipeCG 2015
RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis Lapierre et al. EquipeVC May 2014
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA Thierry et al. EquipeMY Apr 2014
9 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés